Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- P450 DB Provides Valuable Information on Drug Interactions: FQS, Shionogi
September 24, 2001
- IFN Alfacon, Insulin Aspart to Be Launched by Year-end
September 24, 2001
- Ono Discovers Promising CCR5 Receptor Antagonist Candidates
September 24, 2001
- BUSINESS NEWS IN BRIEF -2-
September 24, 2001
- Quintiles, Medical Corporation LTA Form PI Scientific Alliance
September 24, 2001
- BUSINESS NEWS IN BRIEF -3-
September 24, 2001
- Sysmex: Immune Agglutination Determination System PAMIA-40i
September 24, 2001
- Korosho to Assess Pros & Cons in Promoting R&D of New Technology: HIB Director
September 24, 2001
- M&A Inevitable for Japanese Drug Companies: Nikko Solomon's Analyst
September 24, 2001
- FY2001 Korosho White Paper Stresses Importance of Social Security as Safety Net
September 24, 2001
- 9 Active Ingredients to Be Approved in September
September 24, 2001
- PMSB to Take Measures to Ensure Quality of Imported Medical Devices
September 24, 2001
- REGULATORY NEWS IN BRIEF
September 24, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 24, 2001
- Taisho, Tanabe Agree to Integrate Their Business
September 24, 2001
- GEYMS Launches New Multislice CT "LightSpeed Ultra" in Japan First
September 24, 2001
- DIAGNOSTIC NEWS IN BRIEF
September 24, 2001
- Terumo Takes Over Home Oxygen Business from Sumitomo Bakelite
September 24, 2001
- Sankyo to Give Greater Importance to Clinic Market for Life-style Diseases
September 24, 2001
- Takara Launches Nexell's Magnetic Cell Separation System from Nexell
September 24, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…